One Two
Prof. Dr. med. Alexander Pfeifer

of the Institute of Pharmacology and Toxicology
Rheinische Friedrich-Wilhelms-University Bonn
BMZ 2G014/15
Sigmund-Freud-Str. 25
D-53105 Bonn

[Email protection active, please enable JavaScript.]

Tel: +49-228-287-51300/51302
Fax: +49-228-287-51301

You are here: Home Research/Groups Schlicker

Schlicker group

Prof. Dr. med. Eberhard Schlicker


Key research interests

  • Characterization of the cannabinoid CB1 receptor and of the endothelial cannabinoid receptor, also in vivo and also under pathophysiological conditions
  • Identification of histamine H1, H2, H3 and H4 receptors and investigation of ad hoc synthesized ligands
  • Atypical ß-adrenoceptors: Search for models and investigation of ad hoc synthesized ligands


  • Superfusion technique (determination of transmitter release)
  • Biochemical methods (radioligand binding, Western blot, RT-PCR)
  • in vivo studies (in cooperation)
  • Synthesis of novel ligands (in cooperation)

Important publications

  • Kurz CM, Baranowska U, Łupiński S, Göthert M, Malinowska B, Schlicker E: Urethane, but not pentobarbitone, attenuates presynaptic receptor function in pithed rats: a contribution to the choice of anaesthetic. Brit J Phar­ma­col 157, 1474-1482 (2009)

  • Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, Zimmer A: Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316, 1494-1497 (2007)
  • Kozłowska H, Baranowska M, Schlicker E, Kozłowski M, Laudański J, Malinowska B: Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. J Hypert 25, 2240-2248 (2007)

  • Zakrzeska A, Schlicker E, Kwolek G, Kozłowska H, Malinowska B: Positive inotropic and lusitropic effects mediated via the low affinity state of ß1-adreno­ceptors in pithed rats. Brit J Pharmacol 146, 760-768 (2005) 

  • Liedtke S, Flau K, Kathmann M, Schlicker E, Stark H, Meier G, Schunack W: Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists. Naunyn-Schmiedeberg's Arch Pharma­col 367, 43-50 (2003)

  • Kathmann M, Weber B, Zimmer A, Schlicker E: Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice. Brit J Pharmacol 132, 1169-1173 (2001)


Document Actions